SCHEDULE: RTW Investments Amends Axsome Therapeutics Stake
Beneficial Ownership Disclosure
RTW Investments, LP and Roderick Wong, M.D. have filed an amended Schedule 13G, disclosing a 3.1% beneficial ownership stake in Axsome Therapeutics, Inc.
Summary
- RTW Investments, LP and Roderick Wong, M.D. filed Amendment No. 4 to Schedule 13G.
- Beneficially own 1,516,903 shares of Axsome Therapeutics, Inc. Common Stock.
- This represents 3.1% of the outstanding shares of Axsome Therapeutics, Inc.
- The percentage is calculated based on 49,236,365 shares outstanding as of April 28, 2025, as reported in Axsome's Form 10-Q filed on May 5, 2025.
- The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: A Schedule 13G filing is a routine disclosure of beneficial ownership and typically does not convey positive or negative sentiment regarding the company's operations or financial performance. This amendment indicates a passive investment below the 5% threshold.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership changes.
Key Dates
| Date | Description |
|---|---|
| 2025-04-28 | Date as of which 49,236,365 shares of Axsome Therapeutics, Inc. Common Stock were outstanding, as reported in the company's Form 10-Q. |
| 2025-05-05 | Date Axsome Therapeutics, Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2025-06-30 | Date of event which required the filing of this statement (change in beneficial ownership triggering the amendment). |
| 2025-08-14 | Date the Schedule 13G Amendment No. 4 was signed and filed by RTW Investments, LP and Roderick Wong, M.D. |
Keywords
Axsome Therapeutics, RTW Investments, Roderick Wong, Schedule 13G, Beneficial Ownership, Common Stock, Biotechnology, Pharmaceuticals, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.